Discover 1,070 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,070
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Salt Lake City UT, Sacramento CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase2, Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Location: Salt Lake City UT, South Jordan UT, Twin Falls ID,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05256225
Phase3, Recruiting
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
for
Melanoma (Skin Cancer)
Location: Salt Lake City UT, Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT07556380
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Salt Lake City UT, Sacramento CA, Duarte CA, Orange CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase1, Recruiting
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Salt Lake City UT, Aurora CO, Phoenix AZ,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
for
Colo-rectal Cancer
Location: Salt Lake City UT, Kansas City KS, Iowa City IA,
Sponsor: NSABP Foundation Inc
Sex: All
Age: 18+
Code: NCT07058012
Phase2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Salt Lake City UT, Twin Falls ID, Boise ID, Meridian ID,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase3, Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Salt Lake City UT, Los Angeles CA, Portland OR,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Salt Lake City UT, Twin Falls ID, Boise ID, Meridian ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase3, Recruiting
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Salt Lake City UT, Los Angeles CA, San Antonio TX,
Sponsor: Kestrel Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07458347
Phase1, Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Salt Lake City UT, Scottsdale AZ, San Francisco CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07491445
Phase3, Recruiting
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
for
Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Male
Age: 18+
Code: NCT07093177
Recruiting
The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
for
Ovarian Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Female
Age: 21+
Code: NCT06665945
Recruiting
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT05405387
Phase2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Salt Lake City UT, Denver CO, Phoenix AZ, Duarte CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Salt Lake City UT, Los Angeles CA, Tucson AZ, Calgary,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase3, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Salt Lake City UT, Aurora CO, Albuquerque NM,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase2, Phase3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Salt Lake City UT, Boise ID, Meridian ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase2, Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
for
Cervical Carcinoma, Human Papillomavirus Infection
Location: Salt Lake City UT, Albuquerque NM, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 25+
Code: NCT07281430
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
for
Recurrent Chronic Lymphocytic Leukemia,
Location: Salt Lake City UT, Sacramento CA, Duarte CA, Irvine CA,